The development of an integral and global treatment to improve the quality of life in those withType II Diabetes Patients is challenging, thus a whole body Photobiomodulation (PBM) therapy program is proposed as an effective option.
Adults aged 30 to 70 years.
Diagnosed with Type 2 Diabetes Mellitus (T2DM) according to the American Diabetes Association (ADA) criteria.
HbA1c levels between 6.5% and 10% at screening.
Stable diabetes management regimen (medications and lifestyle) for at least three months prior to enrollment
Presence of severe diabetic complications (e.g., end-stage renal disease, proliferative diabetic retinopathy).
History of photosensitivity or medical conditions exacerbated by light exposure.
Use of medications or supplements known to significantly alter glucose metabolism, other than current stable diabetes management.
Pregnant or lactating women.
University of Malaga
Lead sponsor
clinical professor
Collaborator